Advances in the assessment and control of the effector functions of therapeutic antibodies
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the assessment and control of the effector functions of therapeutic antibodies
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 10, Issue 2, Pages 101-111
Publisher
Springer Nature
Online
2011-02-01
DOI
10.1038/nrd3365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP-Mediated Therapeutic Protein-Drug Interactions
- (2010) Jang-Ik Lee et al. CLINICAL PHARMACOKINETICS
- Antibodies to watch in 2010
- (2010) Janice M. Reichert mAbs
- Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding
- (2010) Damian Houde et al. MOLECULAR & CELLULAR PROTEOMICS
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
- (2010) Darius Ghaderi et al. NATURE BIOTECHNOLOGY
- Expression systems for therapeutic glycoprotein production
- (2009) Yves Durocher et al. CURRENT OPINION IN BIOTECHNOLOGY
- Differences in binding and effector functions between classes of TNF antagonists
- (2009) Taruna Arora et al. CYTOKINE
- Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia
- (2009) X. Zhao et al. HAEMATOLOGICA
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- On-Line CE−LIF−MS Technology for the Direct Characterization of N-Linked Glycans from Therapeutic Antibodies
- (2008) Lynn A. Gennaro et al. ANALYTICAL CHEMISTRY
- Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
- (2008) M. Peipp et al. BLOOD
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
- Molecular engineering and design of therapeutic antibodies
- (2008) Leonard G Presta CURRENT OPINION IN IMMUNOLOGY
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The effect of Fc glycan forms on human IgG2 antibody clearance in humans
- (2008) X. Chen et al. GLYCOBIOLOGY
- Engineering therapeutic monoclonal antibodies
- (2008) Xiao-yun Liu et al. IMMUNOLOGICAL REVIEWS
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
- Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu
- (2007) Y.-T. Tai et al. BLOOD
- Glycosylation of Recombinant Antibody Therapeutics
- (2005) Royston Jefferis BIOTECHNOLOGY PROGRESS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now